Results 1 to 7 of 7
Page 1 of 1
TypeTitleAuthor(s)YearViews
Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein markerChen, L; Ho, DWY; Lee, NPY; Sun, S; Lam, B; Wong, KF; Yi, X; Lau, GK; Ng, EWY; Poon, TCW; Lai, PBS; Cai, Z; Peng, J; Leng, X; Poon, RTP; Luk, JM2010287
 
Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinomaLee, NP; Chen, L; Lin, MC; Tsang, FH; Yeung, C; Poon, RT; Peng, J; Leng, X; Beretta, L; Sun, S; Day, PJ; Luk, JM2009185
 
SELDI protein chip technology for the detection of serum biomarkers for liver diseaseChen, L; Fatima, S; Peng, J; Leng, X200982
 
Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrenceYi, X; Luk, JM; Lee, NP; Peng, J; Leng, X; Guan, XY; Lau, GK; Beretta, L; Fan, ST200894
 
Artificial neural networks and decision tree model analysis of liver cancer proteomesLuk, JM; Lam, BY; Lee, NPY; Ho, DW; Sham, PC; Chen, L; Peng, J; Leng, X; Day, PJ; Fan, ST2007126
 
Applicability of proteomic biomarkers set to distinguish hepatocellular carcinoma from non-tumor and healthy liver tissuesLuk, JMC; Lam, BYH; Yi, X; Peng, J; Leng, X; Fan, ST200575
 
Applicability of proteomic biomarkers set to distinguish hepatocellular carcinoma from non-tumor and healthy liver tissuesLuk, JMC; Lam, BKY; Yi, X; Peng, J; Leng, X; Fan, ST200577
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download